Does BPC-157 Increase Cancer Risk?

In this article, we will introduce BPC157, a peptide consisting of 15 amino acids, and its potential influence on cancer risk. Despite some claims, there is no clear scientific evidence suggesting a link between BPC157 and cancer. We will also discuss the need for further research and clinical trials to fully understand this potential relationship.
Frederika Malichová

Frederika Malichová

Neuroscientist at the University Of Cambridge.

A blue image with text saying "Does BPC157 influence Cancer Risk"

BPC-157 and Cancer Risk

Although we see claims saying that BPC157, a peptide, can increase the risk of cancer, there is no scientific evidence suggesting this.

We recommend always consulting your health status and any substances that might be influencing your conditions with a healthcare professional.

What is BPC-157?

BPC 157 stands for the body protection compound 157. It is a pentadecapeptide, which means that it consists of 15 amino acids. Similarly to TB-500, it has recently gained a lot of attention on social media.

Naturally, a partial sequence of BPC157 can be found in human gastric juice.

BPC-157 had been suggested to have healing effects on the gastrointestinal tract and various other organs and tissues [1, 2, 3, 4, 5, 6].

In addition, it has been shown to contribute to angiogenesis (a process of forming new blood vessels). Angiogenesis is a crucial process for healing and recovery in many tissues. Moreover, BPC157 increases vessel density both in vivo and in vitro (in living organisms and in laboratory test tubes respectively) and speeds the process of recovery of blood flow in ischemic muscle tissue.

BPC157 also shows protective activity in organs and tissues and in preclinical safety evaluations, it did not show any serious toxicity and is well-tolerated in animals [2]. This suggests its potential in treatment.

In fact, it has been suggested as a s potential treatment for conditions such as COVID-19, as it improves vascular integrity, and immune response and reduces proinflammatory profiles, which reduces critical levels of disease.

Although BPC 157 has shown promising results in preclinical studies, further research and clinical trials need to be done in order to determine its potential therapeutic application and safety in humans.

Can BPC-157 cause cancer?

There isn't enough evidence to answer exactly whether BPC-157 causes cancer.

Although claims that BPC157 can influence the risk of cancer are being made, the connection between BPC-157 and cancer is not crystal clear. In fact, it is not clear at all and research studies need to be done in order to understand whether BPC-157 can influence the risk of cancer.



This article does not offer health advice. BPC-157 is an experimental drug, with most of its proclaimed health benefits coming from studies conducted on small rodents. Further research is needed to understand its safety in humans.

Frederika Malichová

Frederika Malichová

Frederika is a postgraduate researcher at the University of Cambridge, where she investigates new biomarkers for Frontotemporal Dementia and other tauopathies. Her research has been published at prestigious conferences such as the Alzheimer’s Association International Conference 2023. She obtained her BSc in Biomedical Sciences from UCL, where she worked closely with the UK Dementia Research Institute.